Cannanalytica is a Malta and London based consultancy firm specialising in the Global medical cannabis industry.
We offer our regulatory, EU GMP certification and business development consultancy services to investors and Licensed Producers who are currently present or planning to enter into the medical cannabis space. Our Team of business executives, regulatory experts and QPs/QAs with vast experience in the pharma industry are perfectly placed to advise our clients on medical cannabis projects within Europe.
Certification and Compliance
EU GMP certification and compliance are the cornerstones of the medical cannabis industry in Europe. All medical cannabis sold in Europe needs to be produced under EU GMP and later tested in an EU GMP facility before being released, together with GDP certification for warehousing and distribution.
CannAnalyica has a team of experienced professionals who assist and advise our clients to ensure compliance at every stage of their business processes such as:
Analytical Testing • Batch Release • Warehouse & Eu Distribution
Pharmaceutical Packaging – Audits of Manufacturing Sites
Pharmacovigliance Complaince – GMP Ancillary Services
Audits for existing facilities
Cannanalytica can assist clients by auditing their facilities before commencing the EU GMP certification process. The objective of these audits is to identify the gaps between the facility’s standards and processes and the EU GMP benchmark. The Cannanalytica Team of QP’s and QA’s will then advise our clients on how to bridge the gaps in the most efficient and time effective manner in order to ensure achieving EU GMP standards in the quickest timeline possible.
Licenses & Legislation
As more countries are issuing licenses for medical cannabis cultivation and import, our Team at Cannanalytica can help investors assess the different opportunities and decide on which territories are suitable for their projects. After identifying the territory, our Team at Cannanalytica can project manage the application phase for our clients up the granting of the license by the regulator of the chosen territory.
Legislation in different EU territories – Medical Cannabis legislation in Europe is a complex landscape, with different laws applying to different territories. Moreover, legislation and regulation are constantly changing as different countries open up to medical cannabis in one form or another. The Cannanalytica team of regulatory experts assist our clients by guiding them through the different legislative frameworks to help them understand what can be done where, by who and how. Hublot replica watches
One of Cannanalytica’s offices is in Malta, which has enacted the most progressive legislation on medical cannabis in Europe resulting in over ten international medical cannabis companies applying for a license in Malta in under one year.
For more information on the new legislation can be found here.
CannAlytica offers a full set of set of services for companies who are planning to apply for a license in Malta:
Company structure • Fiscal Set up • IP registration • License Application • Tax Advisory
Qualified Persons Services (QP)
• Qualification of the entire pharmaceutical supply chain both upstream and downstream
including audits (if required).
• Definition of testing scope and release specification for the European Union,
• Review of manufacturing and testing records, checking for compliance with EU-GMP
• Receipt of the medication, Incoming inspection and storage under quarantine.
• Sampling and batch testing.
• Release decision criteria.
• CoA (Certification of Analysis), CoC (Certification of Compliance) with EU-GMP Guidelines.
• Archiving of retained samples and documentation.